a r t I C l e S
Alzheimer's disease is the most common type of dementia and is characterized by insidious degeneration of brain systems that subserve memory and cognition. Accumulation and aggregation of the Aβ peptide in the extracellular space of the brain is a pathological hallmark of Alzheimer's disease. Aβ is produced in neurons by sequential proteolytic cleavage of the amyloid precursor protein (APP) by β-and γ-secretase 1 . Under normal conditions, Aβ is secreted into the interstitial fluid (ISF) of the brain, where it is present in a soluble form throughout life 2 . In Alzheimer's disease pathogenesis, Aβ aggregates into higher-order species such as soluble oligomers and insoluble amyloid plaques in a concentration-dependent manner. As amyloid plaques are extracellular structures, the concentration of Aβ in the ISF is likely to be a key determinant of whether and when Aβ will aggregate 3 . Consistent with this hypothesis, we have recently shown that ISF Aβ concentration is closely associated with amyloid plaque growth and formation in vivo 4 .
In Alzheimer's disease-affected brain, amyloid plaque deposition is most prominent in the 'default-mode network'-a network of brain regions that shows elevated metabolic activity and aerobic glycolysis during undirected mentation [5] [6] [7] [8] [9] [10] . Indeed, default network dysfunction is present in Alzheimer's disease patients 11 as well as cognitively normal adults who harbor appreciable amyloid burden 12, 13 . However, the mechanism underlying the vulnerability of specific brain regions to amyloid deposition in Alzheimer's disease is not known. Given the near direct proportionality between neuronal energy consumption and neurotransmitter cycling in vivo 14 , this correspondence raises the possibility of a relationship between patterns of neuronal activity throughout life and the topography of amyloid deposition in Alzheimer's disease. Evidence from our laboratory and others suggests that synaptic activity regulates Aβ production and secretion into the ISF in vitro 15, 16 and in vivo 17, 18 . For example, electrical stimulation of the perforant pathway increases ISF Aβ in hippocampus, whereas blockade of synaptic vesicle exocytosis decreases ISF Aβ. However, the relationship between endogenous regional differences in neuronal activity and amyloid deposition remains unknown. Herein, we provide data suggesting that regional differences in endogenous neuronal activity dynamically regulate Aβ levels and have implications for the development of Aβ-related pathology.
RESULTS

Regional plaque deposition in aged Tg2576 mouse brain
In Alzheimer's disease, amyloid deposition is most prominent in brain areas that comprise the default network. Core regions of the default network in human cortex include medial and lateral parietal, posterior cingulate, retrosplenial and medial prefrontal areas, as well as the hippocampal formation. To begin to elucidate the mechanisms that regulate region-specific amyloid deposition, we first characterized the distribution of Aβ deposition in APP transgenic (Tg2576) 19 mice, which express a mutated form of amyloid precursor protein (APP). Brain sections from Tg2576 mice 17.5 ± 0.5 months old were immunostained with biotinylated 3D6 antibody, to Aβ amino acids 1-5 (anti-Aβ [1] [2] [3] [4] [5] ) to determine the percentage area occupied by Aβ plaques Amyloid-b (Ab) plaque deposition in specific brain regions is a pathological hallmark of Alzheimer's disease. However, the mechanism underlying the regional vulnerability to Ab deposition in Alzheimer's disease is unknown. Herein, we provide evidence that endogenous neuronal activity regulates the regional concentration of interstitial fluid (ISF) Ab, which drives local Ab aggregation. Using in vivo microdialysis, we show that ISF Ab concentrations in several brain regions of APP transgenic mice before plaque deposition were commensurate with the degree of subsequent plaque deposition and with the concentration of lactate, a marker of neuronal activity. Furthermore, unilateral vibrissal stimulation increased ISF Ab, and unilateral vibrissal deprivation decreased ISF Ab and lactate, in contralateral barrel cortex. Long-term unilateral vibrissal deprivation decreased amyloid plaque formation and growth. Our results suggest a mechanism to account for the vulnerability of specific brain regions to Ab deposition in Alzheimer's disease. a r t I C l e S in brain regions of interest. We found progressively higher Aβ plaque burden across barrel (3.96% ± 0.69), cingulate (9.00 ± 1.59) and piriform (16.54 ± 4.07) cortices (Fig. 1a-c) . Aβ plaque burden in hippocampus (5.51 ± 1.45) was similar to that in barrel cortex; striatum (0.62 ± 0.11) had the least plaque deposition of all regions examined (Fig. 1a-c) . Tg2576 mice thus show region-specific Aβ deposition that is very similar to the pattern observed in human Alzheimer's disease.
To determine whether fibrillar amyloid plaques showed a distribution similar to Aβ immunopositive plaques, we stained brain sections from aged Tg2576 mice with the amyloid-specific dye X-34. In accord with the pattern of Aβ immunopositive plaque deposition, we found that the percentage area occupied by X-34-positive amyloid plaque deposition was progressively higher in barrel (0.27% ± 0.03), cingulate (1.22 ± 0.34) and piriform (2.90 ± 0.40) cortices. Amyloid deposition in hippocampus (0.43 ± 0.09) was similar to that in barrel cortex. Amyloid was not detected in striatum (Fig. 1d-i) . These results suggest that regional differences in Aβ and amyloid plaque deposition are present in aged Tg2576 mouse brain and that Tg2576 mice represent a useful model in which to examine mechanisms underlying regional vulnerability to Aβ and amyloid plaque deposition.
ISF Ab predicts region-specific plaque deposition
As we have previously demonstrated that the concentration of Aβ in the ISF is closely associated with amyloid plaque growth and formation in vivo, we hypothesized that the steady-state concentration of ISF Aβ in each brain region early in life, before plaque deposition, would predict the degree of subsequent plaque deposition in aged mice. To test this hypothesis, we performed in vivo microdialysis to measure steadystate ISF Aβ in brain regions of young (age 3.5 ± 0.5 months) Tg2576 mice before the onset of plaque deposition. Using an Aβ x-40 -specific ELISA, we found that steady-state ISF Aβ x-40 concentrations were greatest in piriform cortex (2,296.55 ± 308.35 pg ml −1 ), intermediate in barrel cortex (824.16 ± 112.81) and hippocampus (1,150.10 ± 130.71) and lowest in striatum (184.74 ± 25.71; Fig. 2a) . ISF Aβ x-40 concentrations in young mice before plaque deposition therefore predict the amount of both Aβ (Fig. 2b) and fibrillar amyloid (Fig. 2c) plaque deposition in aged mice in a region-specific manner. We next sought to determine whether the concentration of the more amyloidogenic form of Aβ, Aβ x-42 , in each brain region of young mice predicts the level of plaque deposition in aged mice. Consistent with our data regarding regional ISF Aβ x-40 concentrations, an Aβ x-42 -specific ELISA showed that ISF Aβ x-42 concentration was greatest in piriform cortex (104.94 ± 30.21 pg ml −1 ), intermediate in barrel cortex (48.24 ± 6.79) and hippocampus (44.31 ± 8.25) and lowest in striatum (9.47 ± 1.46; Fig. 2d) . Therefore, regional ISF Aβ x-42 concentration in young mice also predicts the degree of regional Aβ (Fig. 2e) and amyloid ( Fig. 2f) plaque deposition in aged mice.
Next, we assessed whether regional differences in ISF Aβ levels were present in young wild-type (B6SJL) mice. In accord with our findings in APP transgenic mice, mouse ISF Aβ x-40 concentrations were significantly greater in hippocampus (148.51 ± 17.93 pg ml −1 ) than in striatum (47.4 ± 11.46; P = 0.0032; Supplementary Fig. 1a ). This result suggests that regional differences in ISF Aβ concentration are intrinsic to normal brain physiology. Together, these data suggest that steady-state ISF Aβ levels in young mice predict the degree of Aβ and amyloid plaque deposition in a region-specific manner.
ISF lactate predicts region-specific ISF Ab As the default network shows elevated cerebral metabolism during resting conditions, one possibility is that elevated metabolic activity in specific brain regions throughout life regulates the ultimate distribution of amyloid deposition. Previous data suggest that synaptic activity regulates soluble extracellular Aβ levels in vitro and in vivo. As ISF Aβ concentration is closely associated with amyloid plaque growth and formation, we hypothesized that regional differences in baseline neuronal activity would be proportional to regional steady-state ISF Aβ concentration in Tg2576 mice before the onset of plaque deposition. Previous data suggest that neuronal activity directly regulates extracellular lactate concentration in vitro 20 and in vivo 21 . To further establish ISF lactate as a marker of neuronal activity, we pharmacologically manipulated neuronal activity during in vivo microdialysis with concurrent intraparenchymal electroencephalogram (EEG) recording in young Tg2576 mice. To determine whether increased neuronal activity increases ISF lactate and Aβ, we administered picrotoxin (12.5 µM; PTX), a GABA A receptor antagonist, by means of reverse microdialysis. Infusion of PTX into hippocampus increased hippocampal EEG amplitude (Fig. 3a) and ISF lactate compared to basal conditions (PTX, 129.6 ± 6.4% of basal; basal, 100.0 ± 8.76; P = 0.0342; Fig. 3b and Supplementary Fig. 2a ). In accord with previous data 18 , PTX also significantly increased hippocampal ISF Aβ x-40 concentration relative to basal conditions (PTX, 125.8 ± 5.16% of basal; basal, 100.0 ± 5.21; P = 0.0126; Fig. 3c and Supplementary Fig. 2b ). To determine whether depression of local neuronal activity reduces ISF lactate and Aβ, we administered the voltage-gated sodium channel blocker tetrodotoxin (5 µM; TTX) by means of reverse microdialysis. Compared to basal conditions, TTX reduced EEG amplitude (Fig. 3a) and ISF lactate in hippocampus (TTX, 69.62 ± 2.69% of basal; basal, 100.0 ± 8.75; P = 0.0160; Fig. 3b and Supplementary Fig. 2a) . Consistent with previous data 17 a r t I C l e S of basal; basal, 100.0 ± 5.21; P = 0.0015; Fig. 3c and Supplementary  Fig. 2b ). Across basal, PTX treatment and TTX treatment conditions, ISF lactate significantly correlated with ISF Aβ (Pearson r = 0.7645, P < 0.0001; Fig. 3d ). Together, these data suggest that increasing neuronal activity increases, and decreasing neuronal activity decreases, ISF lactate concentration and suggest that ISF lactate is a marker of neuronal activity in vivo.
To test the hypothesis that regional differences in ISF lactate are proportional to regional steady-state ISF Aβ concentration before the onset of plaque deposition, we next performed in vivo microdialysis to measure steady-state ISF lactate in several brain regions of young Tg2576 mice. We found that ISF lactate was greatest in piriform cortex (142.47 ± 10.19% of striatal value), intermediate in barrel cortex (124.94 ± 11.58) and hippocampus (119.3 ± 10.53) and lowest in striatum (100.0 ± 11.93). ISF lactate was thus commensurate with steady-state ISF Aβ x-40 ( Fig. 4a) and Aβ x-42 ( Fig. 4b) concentrations in young Tg2576 mice. Moreover, steady-state ISF lactate was proportional to subsequent Aβ ( Fig. 4c) and amyloid ( Fig. 4d ) plaque deposition on a region-specific basis. To test whether the relationship between basal ISF lactate and ISF Aβ also held in wild-type mice, we measured ISF lactate in hippocampus and striatum of young B6SJL mice. In accord with our data in Tg2576 mice, ISF lactate concentration was closely associated with mouse ISF Aβ x-40 concentration in young B6SJL mice (Supplementary Fig. 1b) . These results suggest that regional differences in ISF lactate in young mice before plaque deposition are closely associated with steady-state ISF Aβ concentration and subsequent plaque deposition in Tg2576 mice.
As steady-state ISF Aβ concentration is the result of a balance between the rates of Aβ production and clearance, we next sought to determine whether regional differences in ISF Aβ clearance rate might be associated with steady-state ISF Aβ levels in young Tg2576 mice and might therefore contribute to region-specific Aβ deposition. To assess this possibility, we performed in vivo microdialysis in several brain regions of young Tg2576 mice. During the microdialysis sampling period, mice were treated intraperitoneally with compound E (10 mg per kilogram body weight), a potent γ-secretase inhibitor, to rapidly halt Aβ synthesis and permit determination of ISF Aβ elimination half-life (t 1/2 ) as previously described 2 . ISF Aβ x-40 t 1/2 did not differ significantly across barrel cortex (0.99 ± 0.11 h), hippocampus (0.97 ± 0.03) and striatum (1.21 ± 0.08; P = 0.1175) in the brains of young Tg2576 mice ( Supplementary  Fig. 3a,b) , suggesting that regional variation in ISF Aβ clearance rate is not sufficient to account for the pattern of plaque deposition in aged Tg2576 mice.
APP processing does not predict regional ISF Ab levels Amyloidogenic processing of full-length APP by β-and γ-secretase is necessary for Aβ generation. β-secretase cleavage of APP holoprotein produces C-terminal fragment (CTF)-β, whereas non-amyloidogenic a r t I C l e S processing of APP by α-secretase produces CTF-α and precludes Aβ generation. Differential expression or processing of APP holoprotein across brain regions could thus contribute to regional differences in steady-state ISF Aβ concentrations and plaque deposition. To test this possibility, we performed western blot analyses to measure APP holoprotein, CTF-β and CTF-α across cortical regions that harbor differential ISF Aβ concentrations and develop differential plaque burden. Despite marked differences in steady-state ISF Aβ concentrations and plaque deposition, expression levels of full-length APP, CTF-β and CTF-α were similar in piriform, cingulate and barrel cortices (P = 0.9437, 0.9821 and 0.6348 for APP, CTF-β and CTF-α, respectively; Supplementary Fig. 4a-c) .
To determine the role of APP expression and processing in regionspecific regulation of Aβ concentration in subcortical structures, we next measured APP holoprotein, CTF-β and CTF-α in whole cortex, hippocampus and striatum. Relative to hippocampus and striatum, APP holoprotein expression was significantly greater in cortex (P = 0.0017; Supplementary Fig. 4d,f) . CTF-β expression was significantly lower in striatum than in hippocampus (P = 0.0245; Supplementary  Fig. 4e,f) , whereas CTF-α expression did not differ across cortex, hippocampus and striatum (P = 0.9761; Supplementary Fig. 4e,f) . Together, these results suggest that regional APP expression and processing profiles are not associated with local differences in steadystate ISF Aβ or plaque deposition and are thus not sufficient to account for the pattern of amyloid deposition observed in Tg2576 mice.
Vibrissal activity regulates ISF Ab levels
The present data suggest that regional differences in basal ISF lactate concentrations are closely associated with steady-state ISF Aβ concentrations and predict subsequent plaque deposition. We next sought to determine whether a causal relationship between physiological neuronal activity and both steady-state ISF Aβ and lactate concentrations exists in vivo. In rodents, each vibrissa is somatotopically mapped onto a defined cluster of neurons termed a 'barrel' in primary somatosensory cortex 22 . There, neurons in each barrel respond to stimulation of the vibrissa to which they are synaptically connected. Vibrissal stimulation increases 23 , whereas vibrissal removal decreases 24 , neuronal activity in barrel cortex. Therefore, the vibrissae-barrel system represents a noninvasive physiological circuit in which to examine the relationship between physiological neuronal activity and ISF Aβ concentrations in vivo.
To determine whether a manipulation that causes a physiological reduction in neuronal activity could reduce ISF Aβ concentrations, we performed vibrissal deprivation during in vivo microdialysis in barrel cortex of young Tg2576 mice. After establishing stable basal ISF Aβ concentrations, we trimmed all vibrissae contralateral to the microdialysis probe to within 1 mm of the facial pad. Acute trimming of vibrissae reduced ISF Aβ in barrel cortex by 22% compared to baseline (P = 0.0107; Fig. 5a,c) . Similarly, trimming of vibrissae reduced ISF lactate in barrel cortex by 19% relative to basal conditions (P = 0.0127; Fig. 5b,c) .
To determine whether a manipulation that causes a physiological increase in neuronal activity is sufficient to increase ISF Aβ concentrations, we next performed unilateral mechanical vibrissal stimulation during in vivo microdialysis in barrel cortex of a separate cohort of young Tg2576 mice anesthetized with ketamine-xylazine. a r t I C l e S during wake and quiet sleep more closely than under other forms of anesthesia 25 . We found that unilateral mechanical vibrissal stimulation (5-7 Hz, 4 s burst, 4 s inter-burst interval) for 30 min increased ISF Aβ x-40 in barrel cortex by 31% relative to control conditions (P = 0.0446; Fig. 5d ).
ISF lactate levels show diurnal fluctuation
The sleep/wake cycle is associated with diurnal fluctuation of ISF Aβ; ISF Aβ concentration is greater during wakefulness and lesser during sleep 26 . Previous data from humans and animal models suggest that periods of wakefulness are associated with increased synaptic strength and periods of sleep are associated with decreased synaptic strength [27] [28] [29] . Therefore, we reasoned that diurnal fluctuation of ISF Aβ might be linked with lactate levels throughout the sleep/wake cycle.
To assess this possibility, we performed in vivo microdialysis in hippocampi of young Tg2576 mice housed in 12 h light/12 h dark conditions. Consistent with our previous findings, ISF Aβ 1-x concentrations were 21% greater during the dark period than during the light period (P = 0.0314; Fig. 6a,c) . Moreover, ISF lactate concentrations were 23% greater during the dark period than during the light period (P = 0.0066; Fig. 6b,c) . ISF Aβ 1-x concentrations were thus correlated with ISF lactate concentrations across the sleep/wake cycle (Pearson r = 0.6351, P < 0.0001; Fig. 6d ). As mice spent significantly more time awake during the dark period than during the light period (dark, 51.32 ± 1.26 min awake per hour; light, 25.02 ± 2.15; P < 0.0001), these findings suggest that wakefulness, ISF lactate and ISF Aβ are co-regulated and are consistent with the hypothesis that diurnal fluctuation in neuronal activity contributes to the diurnal fluctuation in ISF Aβ in vivo.
Vibrissal deprivation reduces plaque formation and growth
We have previously demonstrated that the concentration of ISF Aβ is closely related to amyloid plaque growth and formation in vivo 4 . As our present data suggest that acute manipulations that alter neuronal activity modulate ISF Aβ concentration, we hypothesized that manipulations that cause longer-term changes in neuronal activity might modulate amyloid plaque growth and formation in vivo.
To test this hypothesis, we used 7-month-old APPswe; PSEN1∆E9 (APP/PS1) 30 bitransgenic mice because this strain develops aggressive fibrillar amyloid deposition beginning at 4-5 months of age. Using in vivo multiphoton microscopy, amyloid plaques in barrel cortex of each hemisphere were visualized with methoxy-X04 under thinnedskull cranial windows to obtain basal measures of individual amyloid plaque size. All vibrissae on the right side of the facial pad were subsequently trimmed to within 1 mm of the face every other day for 28 d. At the conclusion of the 28-d vibrissal deprivation period, amyloid plaques in barrel cortex of each hemisphere were reimaged to assess the effect of vibrissal deprivation on individual amyloid plaque growth. We found that plaque growth was decreased by 78% in the vibrissae-deprived relative to the control hemisphere (P = 0.0014; Fig. 7a-e) . Moreover, new amyloid plaque formation was decreased by 65% in the deprived relative to the control hemisphere (P = 0.0367; Fig. 7a-d,f) .
To determine whether suppression of amyloid plaque growth and formation upon long-term vibrissal deprivation might be attributable to increased glial activation in barrel cortex, brains were sectioned and stained for glial fibrillary acidic protein and Iba-1 to visualize astrocytic and microglial activation, respectively. Confocal microscopy revealed no qualitative difference in astrocytic ( Supplementary  Fig. 5a-c) or microglial (Supplementary Fig. 5d-f ) activation in the deprived hemisphere compared to the control hemisphere. This result suggests that altered glial activation is not likely to contribute to the observed suppression of amyloid plaque growth and formation upon long-term vibrissal deprivation. Taken together, although long-term vibrissal deprivation results in several changes in the brain, the present data are consistent with the hypothesis that physiological neuronal activity regulates amyloid plaque growth dynamics in vivo. a r t I C l e S DISCUSSION Aggregation of Aβ into higher-order structures such as extracellular amyloid plaques is a necessary event in Alzheimer's disease pathogenesis. A fundamental feature of Alzheimer's disease is the preferential deposition of amyloid plaques in distinct brain regions. However, the mechanism by which specific brain regions are rendered vulnerable to amyloid deposition in Alzheimer's disease has heretofore remained unknown. As Aβ aggregation is closely related to ISF Aβ concentration in vivo, elucidating the mechanisms that regulate ISF Aβ concentration has important implications for understanding the etiology of region-specific Aβ deposition in Alzheimer's disease. In the present work, we used in vivo microdialysis to show that ISF Aβ concentrations measured in several brain regions of young Tg2576 mice months before plaque deposition are directly proportional to the degree of subsequent plaque deposition. Moreover, ISF Aβ concentrations in young mice are closely associated with concentrations of baseline ISF lactate, a marker of neuronal activity, on a region-specific basis. Furthermore, we show that physiological changes in neuronal activity are sufficient to dynamically modulate ISF Aβ concentrations and amyloid plaque growth in vivo. Collectively, our results suggest that regional differences in basal neuronal activity level govern region-specific amyloid deposition through long-term regulation of steady-state ISF Aβ concentration.
As sequential proteolysis of APP by β-and γ-secretase is necessary for Aβ generation, several previous reports have examined the regional distribution of this triad as potential mediators of regionspecific Aβ deposition. However, the cerebral distribution of APP, BACE1 and PSEN1 transcripts is not associated with the topography of Aβ deposition in human Alzheimer's disease [31] [32] [33] [34] or APP transgenic mice [35] [36] [37] . Moreover, the regional distribution of γ-secretase activity in APP transgenic mouse brain does not correlate with the pattern of Aβ deposition 38 . Consistent with these previous reports, the present results suggest that although differences in APP expression and processing are present across a subset of brain areas in Tg2576 mice, the pattern of APP expression and processing is not sufficient to account for the pattern of Aβ deposition. Together, these studies suggest that more factors are necessary to drive region-specific Aβ deposition. In addition to region-specific differences in neuronal activity potentially contributing to region-specific differences in Aβ deposition, other possible contributors to the presence of Aβ in specific neural networks include the spread of Aβ aggregates within and into the brain. For instance, exogenous intracerebral 3, 39 or peripheral 40 application of Aβ aggregates can seed cerebral β-amyloidosis. Further, reports suggest that selective overexpression of APP in the cell bodies of neurons in the entorhinal cortex of transgenic mice can elevate soluble Aβ and produce amyloid plaque deposition in the synaptic terminal zone of the dentate gyrus 41, 42 . Thus, transsynaptic propagation mechanisms as well as spread of Aβ pathology through interconnected neural networks might also contribute to the pattern of amyloid deposition observed in Alzheimer's disease.
In the healthy human brain, a specific subset of brain regions-the default network-is preferentially engaged during resting the state. Notably, amyloid deposition in Alzheimer's disease brain is most prominent in regions that comprise the default network. These findings raise the possibility that patterns of normal cerebral metabolism may influence the distribution of amyloid deposition in Alzheimer's disease. In accord with this hypothesis, recent data suggest that the spatial distribution of resting-state aerobic glycolysis (that is, glucose utilization in excess of that used for oxidative phosphorylation despite sufficient oxygen to oxidize glucose to carbon dioxide and water) in cognitively normal adults overlaps closely with the topography of amyloid deposition in Alzheimer's disease. Our present data demonstrating that pharmacological manipulation of neuronal activity directly regulates ISF lactate abundance are consistent with previous animal and human studies and suggest that neuronal activity stimulates aerobic glycolysis in vivo. Given that neuronal activity also increases Aβ production and secretion into the ISF, regional differences in neuronal activity may underlie the spatial relationship between resting-state aerobic glycolysis and amyloid deposition in Alzheimer's disease.
We have previously demonstrated that ISF Aβ concentrations fluctuate diurnally: ISF Aβ concentration is significantly greater during waking conditions than during sleep 26 . Given that neuronal activity directly regulates ISF Aβ levels, we reasoned that diurnal fluctuation of neuronal activity may contribute to diurnal fluctuation of ISF Aβ. Indeed, previous data suggest that periods of wakefulness are associated with net synaptic potentiation and periods of sleep are associated with synaptic downscaling and depression 28 More generally, our results suggest that factors that elevate endogenous neuronal activity over prolonged periods may accelerate progression of Aβ deposition. In support of this hypothesis, recent functional magnetic resonance imaging data suggest that cognitively normal apolipoprotein E (APOE) allele ε4 carriers show elevated resting-state activity in the default network and increased hippocampal activation during a memory encoding task compared to noncarriers 43 . Thus, in addition to apoE isoform-dependent differences in apoE-Aβ interactions 44 , elevated lifetime neuronal activity may be a complementary mechanism by which ε4 expression increases Alzheimer's disease risk. Conversely, factors that reduce activity in vulnerable neural networks may slow the progression of β-amyloidosis and reduce Alzheimer's disease risk. For example, epidemiological evidence suggests that educational attainment is negatively correlated with Alzheimer's disease risk 45 . As default network activity is suppressed during cognitively demanding tasks, one possibility is that education reduces Alzheimer's disease risk by reducing neuronal activity and Aβ generation within the default network.
It is noteworthy that the regional distribution of lesions in mouse models of glutamate-induced excitotoxicity is similar to the distribution of Aβ deposition described herein 46 . As neuronal activity regulates both Aβ and glutamate release at the synapse, the regional differences in basal neuronal activity described here may also underlie the distribution of glutamate-induced excitotoxic lesions. A more detailed understanding of the regional distribution of pre-and postsynaptic elements may provide insight regarding the structural basis of neuronal activity patterns in normal brain and how patterns of neuronal and synaptic activity might contribute to a variety of neurological lesions.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/. (light phase beginning at 6 a.m.) for 2 weeks before recording began. To monitor the sleep-wake cycle, mice were transferred to recording cages maintained in 12 h light/12 h dark conditions (light phase beginning at 6 a.m.) and the miniconnector was connected to flexible recording cables. Mice were habituated to the recording cages for 3 d. At the conclusion of the habituation period, EEG and EMG recording began simultaneously with microdialysis sample collection. EEG and EMG signals were displayed on a monitor and stored in a computer for off-line analysis of sleep states. EEG and EMG recordings were assessed using a P511K A.C. preamplifier (Grass Technologies), digitized with a DigiData 1440A data acquisition system (Molecular Devices) and recorded digitally using pClamp 10.2 (Molecular Devices). EEG and EMG signals were filtered (EEG: high pass, 1 Hz; low pass, 30 Hz; EMG: high pass, 10 Hz; low pass, 100 Hz) and used to identify vigilance states. EEG and EMG recordings were scored semiautomatically using sleep scoring software (SleepSign, Kissei Comtec) and binned into 10-s epochs as wakefulness, rapid eye movement (REM) sleep and non-REM sleep per standard criteria of rodent sleep. Semiautomatic sleep scoring was visually inspected and corrected when appropriate.
thinned-skull cranial window surgery. Thinned-skull cranial windows were prepared on the day of the first multiphoton imaging session as described previously 4 . Briefly, mice were anesthetized under volatile isoflurane and the skin and periosteum were removed to expose the skull. A high-speed drill and microsurgical blade (Surgistar) were used to thin the skull until it was transparent and flexible. One cranial window (2 × 2 mm) was prepared over barrel cortex (bregma -1.5 mm, 3.5 mm lateral to midline) of each hemisphere.
In vivo multiphoton microscopy. Longitudinal multiphoton microscopy to monitor amyloid plaque growth was performed as described previously 4 . Briefly, mice were injected intraperitoneally with the fluorescent amyloid-binding compound methoxy-X04 (ref. 49 ; 5 mg ml −1 ) 24 h before each multiphoton imaging session. Mice were mounted on a custom-built stereotaxic apparatus and a small ring of molten bone wax was applied to the skull surrounding the perimeter of the window to create a water immersion chamber. The cranial window was centered under the objective lens on a two-photon microscope (LSM 510 META NLO system (Carl Zeiss) with a Cameleon Ti:sapphire laser (Coherent Inc.)). Two-photon fluorescence was generated with 750 nm excitation and fluorescence emission was detected at 435-485 nm. A ×10 water-immersion objective (numerical aperture 0.33, Zeiss) was used to create a site map during initial imaging and a ×40 water-immersion objective (numerical aperture 0.75, Zeiss) was used for high-resolution quantification of individual amyloid plaques. Incremental z-stack image series (step distances 10 and 5 µm under ×10 and ×40 objectives, respectively) were acquired from the skull surface to approximately 200 µm into cortex. To determine the effect of long-term vibrissal deprivation on amyloid plaque formation and growth, the same sites of each hemisphere of barrel cortex in each mouse were imaged on day 0 and day 28. Collapsed z-stack images of each amyloid plaque were measured by cross-sectional area using SigmaScan Pro Image Analysis Software (Systat Software) as previously described 4 . Plaques were excluded from analysis if they were located at the edge of the window or showed fluorescence intensity less than the mean intensity of an adjacent background region or if the image acquisition was affected by motion artifacts from heartbeat or respiration. double immunofluorescence. To compare astrocytic and microglia activation in barrel cortex after long-term vibrissal deprivation, mice were transcardially perfused with 0.9% saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer immediately after the final multiphoton imaging session. Brains were removed and postfixed in 4% paraformaldehyde for another 4 h. Coronal free-floating sections (50 µm thick) were cut on a cryostat (Leica). Sections were incubated overnight at 4 °C in a combination of mouse anti-glial fibrillary acidic protein monoclonal antibody (Sigma) and rabbit anti-Iba1 (Wako Chemicals). A secondary antibody mixture of Alexa Fluor 488-conjugated donkey anti-mouse IgG (Invitrogen) and Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories) was used for detection. Sections were imaged using a confocal microscope (Zeiss LSM).
Statistical analysis. Statistical significance was determined by two-tailed t-test if two groups were compared. When variance differed significantly between groups, Welch's t-test was used. One-way ANOVA followed by Tukey's post hoc test for multiple comparisons tests were used when more than two groups were compared. Correlation was determined using Pearson product moment correlation test. All statistical analyses were performed using Prism version 4.0 for Windows (GraphPad). Values were accepted as significant if P < 0.05.
